Reuters logo
BRIEF-GSK's Crohn's disease treatment fails in Phase III trial
August 23, 2013 / 1:37 PM / 4 years ago

BRIEF-GSK's Crohn's disease treatment fails in Phase III trial

Aug 23 (Reuters) - GlaxoSmithKline Plc : * Announces phase III study of Vercirnon in patients with moderate-to-severe

Crohn’s disease did not meet its primary endpoint * New recruitment and dosing in ongoing clinical programme has been suspended

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below